Global Psoriasis Atlas

The first atlas of its kind showing the global distribution of psoriasis. A dynamic, informative and accessible web-based atlas.

GPA logo highres

When the WHO Global Report on Psoriasis called for greater understanding of psoriatic disease epidemiology, the Global Psoriasis Atlas (GPA) was formed. The project is a long term collaboration between IFPA, the International league of Dermatological Societies (ILDS) and the International Psoriasis Council (IPC).

The GPA is the world’s most extensive review of the global burden of psoriasis and provides open access information about the worldwide epidemiology of psoriasis. Its results provide the scientific foundation to fuel IFPA's advocacy.

Subscribe to the Global Psoriasis Atlas Quarterly Newsletter to stay informed on the latest news, publications, collaborations and research.
Subscribe

Visit the Global Psoriasis Atlas

This reliable resource on psoriasis was first published in 2019 and one of the key aims of the GPA website is to provide detailed, open-access information about the worldwide epidemiology of psoriasis. 
The prevalence of psoriasis varies depending on geographic location and genetic background. Considerable gaps still exist in the geographical areas reporting data on incidence and prevalence of psoriasis. Only 41 of over 220 countries and territories in the world have epidemiological data on psoriasis in the general population.

Learn more
Combined Shape
Combined Shape
Combined Shape
Combined Shape
Combined Shape
Combined Shape
Combined Shape

Vision

The vision of the Global Psoriasis Atlas is to become the leading epidemiological resource globally on psoriasis.

Mission

The mission of the GPA is to provide the common benchmark on the burden of psoriasis in all countries and regions throughout the world. The GPA will leverage existing data from publications and registries; where gaps are identified additional studies will be commissioned. The GPA is a long-term project that seeks both to drive continuous improvement in the understanding of psoriasis and uncover how it affects both the individual and society at large.

In 2014, the World Health Organization approved the Resolution on Psoriasis. Shortly thereafter, the Global Report on Psoriasis (2016) was published, highlighting the need for an international atlas to map the burden of disease. These landmarks paved the way for the Global Psoriasis Atlas (GPA).

Since 2019, the Global Psoriasis Atlas has been available in an interactive website format. One of the GPA’s aims is to improve the understanding of psoriasis among different groups of people in every region worldwide, while meeting the highest scientific standards of epidemiological research. In addition to collecting previously published data on psoriasis, the GPA unleashes new findings on the prevalence of psoriasis among adults and children, associated comorbidities, and healthcare access.

The Global Psoriasis Atlas website presents the human face of psoriatic disease by sharing compelling, first-hand experiences from around the world. The faces and stories of our very own IFPA members are featured on the GPA website, revealing the deep impact of psoriatic disease and the true value of the GPA's work.

Language versions

The Global Psoriasis Atlas is now available in Spanish and Arabic!

En Español     باللغة العربية

A disease Atlas is a database organized by geographic zones. It provides updated data about a disease or set of diseases.

This includes the prevalence (the total number of people living with the disease at any one point) and the incidence ( the number of people who are diagnosed with psoriasis in a specific time period). A disease atlas can also include other data such as mortality, risk factors, hospitalizations, research, HC systems measures, and more.

The World Health Organization Resolution WHA67.9 requested that WHO publish a global report on psoriasis, including the global incidence and prevalence, emphasizing the need for further research on psoriasis. The Global Psoriasis Atlas responds to this call and aims to map the global burden of psoriasis using the highest scientific standards. This research will ultimately ensure that people living with psoriasis have the best available care, wherever they live.

The mission of the GPA is to "provide the common benchmark on the complete burden of psoriasis in all countries and regions throughout the world.”

The GPA is a long-term project, driving continuous improvement in the understanding of psoriasis. The study explores how psoriasis affects both the individual and society at large.

The GPA consists of

  • Board of Governors
  • Scientific Advisory Board
  • Steering Committee
  • Collaboration Team
  • Research and Management Team at the University of Manchester
     

The GPA is a collaboration of three leading organizations: IFPA, the International League of Dermatological Societies (ILDS) and the International Psoriasis Council (IPC), the Collaboration Team.

 

The GPA is the world’s most extensive review of the global burden of psoriasis and provides open access information about the worldwide epidemiology of psoriasis. The GPA’s research includes incidence and prevalence of psoriasis, access to care and comorbidities along with other specific research objectives detailed on their website.  

The Global Psoriasis Atlas can be used as:

  • An advocacy tool
  • A source for citations in media and scientific publications
  • A source of accurate data for messaging and materials
  • A tool of to compare the burden of psoriasis across regions and countries. 
The GPA is a collaboration between three leading international organizations in world dermatology: International Federation of Psoriasis Associations (IFPA); International League of Dermatological Societies (ILDS); and International Psoriasis Council (IPC). This long-term project is led and delivered by global experts and led by the academic team at the University of Manchester working in collaboration with research organization from around the world.

Contact Person

  • Sicily 010 linkedin WEBB med bakgrund

    Sicily Mburu, M.D.

    Scientific Officer

    Sicily injects the patient perspective into every stage of the research cycle. Sicily is a health professional with a clinical background and over 10 years experience in the field of global health. Sicily holds a dual MSc in Epidemiology, and Health Economics & Policy.

    sicily.mburu@ifpa-pso.com

    +46 736 997 005